Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × Leiomyosarcoma × Clear all

Phase

Status

Sponsor Class

OTHER 72 INDUSTRY 28 NETWORK 19 NIH 16 UNKNOWN 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Myasthenia Gravis 4 Breast Neoplasms 4 Barrett Esophagus 4 Leiomyoma 3 Carcinoma, Hepatocellular 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Lung Neoplasms 2 Lipoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma in Situ 2 Warts 1 Vaginosis, Bacterial 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Syphilis 1 Sexually Transmitted Diseases 1 Retroperitoneal liposarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pilonidal Sinus 1 Papillomavirus Infections 1 Overweight 1 Ovarian Neoplasms 1 Osteosarcoma 1 Obesity 1 Neutropenia 1

Interventions

nilotinib 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02587169 2015-10-27

GEIS-27

Broto, Javier Martín, M.D.

Phase 1/2 Unknown

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡